This review describes how immune cells and nervous system cells interact in MS, and how researchers are studying those interactions.
The authors describe MS as a disease involving inflammation and damage to the brain and spinal cord. They review factors linked to MS risk. They explain how immune cells and nervous system cells interact in MS. They discuss available treatments that aim to change the course of MS. They also examine newer research tools that may help identify possible treatment targets.
This review is about MS, but it did not study a new group of people. It may interest people with MS who want an overview of current research. It covers how cells in the nervous system and immune system may affect each other. It discusses treatments already available for MS. It also looks at research tools that may help address needs that current care does not meet.
You are reading a review, not a report of a new treatment test. The abstract does not give a participant count or results for any specific treatment. It does not show that a new treatment helps people with MS.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read More10/6/2026
In children with MS, immune attacks on the brain and spinal cord may go unchecked. See what research
Read More10/1/2026
A study links a body chemical to MS inflammation and shows that blocking its source eases symptoms i
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Cell often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.